Pretherapy Ferumoxytol-enhanced MRI for Metastatic Breast Cancer: A New Approach for Predicting Tumor Delivery of Macromolecular Therapeutics?

Overview

Journal Radiol Imaging Cancer

Specialties Oncology
Radiology

Date 2023 Feb 3

PMID 36734849

Authors

Heike E Daldrup-Link

Affiliations

Soon will be listed here.

References

Pohlmann A, Karczewski P, Ku M, Dieringer B, Waiczies H, Wisbrun N . Cerebral blood volume estimation by ferumoxytol-enhanced steady-state MRI at 9.4 T reveals microvascular impact of α1 -adrenergic receptor antibodies. NMR Biomed. 2014; 27(9):1085-93. DOI: 10.1002/nbm.3160. View

Daldrup-Link H, Rydland J, Helbich T, Bjornerud A, Turetschek K, Kvistad K . Quantification of breast tumor microvascular permeability with feruglose-enhanced MR imaging: initial phase II multicenter trial. Radiology. 2003; 229(3):885-92. DOI: 10.1148/radiol.2293021045. View

Ravi H, Arias-Lorza A, Costello J, Han H, Jeong D, Klinz S . Pretherapy Ferumoxytol-enhanced MRI to Predict Response to Liposomal Irinotecan in Metastatic Breast Cancer. Radiol Imaging Cancer. 2023; 5(2):e220022. PMC: 10077095. DOI: 10.1148/rycan.220022. View

Iv M, Samghabadi P, Holdsworth S, Gentles A, Rezaii P, Harsh G . Quantification of Macrophages in High-Grade Gliomas by Using Ferumoxytol-enhanced MRI: A Pilot Study. Radiology. 2018; 290(1):198-206. PMC: 6312434. DOI: 10.1148/radiol.2018181204. View

Toth G, Varallyay C, Horvath A, Bashir M, Choyke P, Daldrup-Link H . Current and potential imaging applications of ferumoxytol for magnetic resonance imaging. Kidney Int. 2017; 92(1):47-66. PMC: 5505659. DOI: 10.1016/j.kint.2016.12.037. View

Zanganeh S, Hutter G, Spitler R, Lenkov O, Mahmoudi M, Shaw A . Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues. Nat Nanotechnol. 2016; 11(11):986-994. PMC: 5198777. DOI: 10.1038/nnano.2016.168. View

Daldrup-Link H, Okuhata Y, Wolfe A, Srivastav S, Oie S, Ferrara N . Decrease in tumor apparent permeability-surface area product to a MRI macromolecular contrast medium following angiogenesis inhibition with correlations to cytotoxic drug accumulation. Microcirculation. 2004; 11(5):387-96. DOI: 10.1080/10739680490457665. View

Aghighi M, Theruvath A, Pareek A, Pisani L, Alford R, Muehe A . Magnetic Resonance Imaging of Tumor-Associated Macrophages: Clinical Translation. Clin Cancer Res. 2018; 24(17):4110-4118. PMC: 6125171. DOI: 10.1158/1078-0432.CCR-18-0673. View

Daldrup-Link H, Mohanty S, Ansari C, Lenkov O, Shaw A, Ito K . Alk5 inhibition increases delivery of macromolecular and protein-bound contrast agents to tumors. JCI Insight. 2016; 1(6). PMC: 4864003. DOI: 10.1172/jci.insight.85608. View

10.

Smith B, Kempen P, Bouley D, Xu A, Liu Z, Melosh N . Shape matters: intravital microscopy reveals surprising geometrical dependence for nanoparticles in tumor models of extravasation. Nano Lett. 2012; 12(7):3369-77. PMC: 3495189. DOI: 10.1021/nl204175t. View

11.

Lee H, Shields A, Siegel B, Miller K, Krop I, Ma C . Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer. Clin Cancer Res. 2017; 23(15):4190-4202. PMC: 6790129. DOI: 10.1158/1078-0432.CCR-16-3193. View